mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.06 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.06 |